Arena Pharmaceuticals, Inc. (ARNA) Social Stream



Arena Pharmaceuticals, Inc. (ARNA): $99.99

0.06 (+0.06%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ARNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 427

in industry

Arena Pharmaceuticals Inc (ARNA) Price Targets From Analysts

Use the tables below to see what analysts covering Arena Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 6 $120 $80 $97.428 $99.99 -2.56%
2021-12-08 7 $120 $71 $94.125 $99.99 -5.87%
2021-12-14 10 $120 $71 $95.428 $99.99 -4.56%
2021-12-21 10 $120 $71 $96.375 $99.99 -3.62%
2022-02-24 10 $100 $71 $93.875 $99.99 -6.12%

The Trend in the Analyst Price Target


ARNA's average price target has moved down $3.36 over the prior 44 weeks.

ARNA reports an average of 48.6% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 15 120 76 97.530 62.79 55.33%
2021-08-01 15 120 76 97.530 61.86 57.66%
2021-09-19 15 120 76 95.250 61.05 56.02%
2021-09-20 15 120 76 95.250 59.86 59.12%
2021-12-08 6 120 71 94.125 54.71 72.04%

ARNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.6 2 0 8 0 0 10

The Trend in the Broker Recommendations


ARNA's average broker recommendation rating worsened by 1.6 over the prior 21 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Arena Pharmaceuticals Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 51.39% of that group.
  • Arena Pharmaceuticals Inc's average analyst price target is greater than 674.15% of Pharmaceutical Products stocks.
  • In terms of how Arena Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 490.76% of that group.
  • ARNA has a lower variance in analysts' estimates than -395.72% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, APLS, ANAB, and AMTI are the three stocks most similar to Arena Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ARNA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6303 seconds.